The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side analysts ...
Hosted on MSN
Valion Bio outlines end-2026 Entolimod GMP validation target as NIAID funds GI-ARS BLA-enabling work
Valion Bio management framed Q1 2026 as the first period following its identity change to VBIO and emphasized federally funded progress for Entolimod under the FDA Animal Rule pathway, saying NIAID ...
Good afternoon. Thank you for attending today's Bio-Rad Second Quarter 2022 Earnings Results Conference Call. My name is Hannah and I will be your moderator for today's call. All lines will be muted ...
SUNRISE, Fla., June 18, 2026 /PRNewswire/ -- Transpire Bio Inc., an integrated, U.S.-based, clinical-stage biopharmaceutical company, announced today that its Chief Financial Officer, LaDuane Clifton, ...
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the promotion of James ...
Mabwell (Shanghai) Bioscience Co. Ltd. and Aditum Bio Management Company LLC have announced the launch of Kalexo Bio, a new company formed in conjunction with an exclusive global license agreement to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results